Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

A medical expert warned of the side effects of the newly launched weight loss drug and advised that the drug should be taken ...

Ozempic, a GLP-1 receptor agonist, has officially launched in India, offering a new treatment option for type 2 diabetes.

Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

With this launch, Ozempic now available in India as a once-weekly injectable formulation of semaglutide. It will be available ...

Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs ...

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally ...

Ozempic, the popular diabetes and weight-loss drug, launches in India starting at ₹8,800. Here are the prices, dosage options ...

Ozempic, launched by Novo Nordisk in India at $24.35 weekly, aims to tap into the growing diabetes and obesity market. Despite competition looming with patent expiration next year, the company ...

Novo Nordisk has launched Ozempic, its once-weekly semaglutide injection, in India with prices starting at Rs 8,800. Approved ...

Ozempic (injectable semaglutide) is a once-weekly treatment indicated as an add-on to diet and exercise for adults with uncontrolled Type 2 diabetes mellitus (T2DM).

Ozempic one of the most sought-after drugs across the world for its Type 2 Diabetes and weight loss treatment will be available in India at a starting weekly dose of 025 mg priced at INR 2200 ...